Cellectis CLLS
NASDAQ CLLS
$1.40 -0.11 (-7.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cellectis (CLLS) Beginning Cash Balance (2024 - 2025)

Updated

Cellectis (CLLS) reported Beginning Cash Balance of $143.25 million for Q1 2025, up 4.8% from $136.71 million a year earlier.

Analysis

Cellectis (CLLS) Beginning Cash Balance (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cellectis 151.51 Mn -601.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 143.25 Mn
Mar 31, 2024 136.71 Mn
API Access

Cellectis Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=CLLS&period=max&api_key=YOUR_API_KEY